Interferon-β1b treatment in neuromyelitis optica

European Neurology

Volumn 62, Issue 3, 2009, Pages 167-170

  Tanaka, Masami ^a,d   Tanaka, Keiko ^b,c   Komori, Mika ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d NONE   (Japan)

Author keywords

Anti aquaporin 4 antibody; Interferon; Multiple sclerosis; Neuromyelitis optica; Relapse

Indexed keywords

INTERFERON BETA SERINE;

ADULT; AGED; ARTICLE; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; RATING SCALE;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649846243     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227277     Document Type: Article

References (15)

1. 1b is effective in relapsing-remitting multiple sclerosis. 1. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-661.
2. 1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 1993;43:662-667.
3. 1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006;67:1242-1249.
4. Wingerchuk DM: Neuromyelitis optica. Adv Neurol 2006;98:319-333.
5. Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG: Neuromyelitis optica. Curr Opin Neurol 2007;20:255-260.
6. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon- Caen O, Gout O: Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007;13:256-259. (Pubitemid 46592781)
7. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expected disability status scale (EDSS). Neurology 1983;33:1444-1452.
8. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wollinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
10. Tanaka K, Tani T, Tanaka M, Saida T, Idezuka J, Yamazaki M, Tsujita M, Nakada T, Sakimura K, Nishizawa M: Anti-aquaporin-4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007;13:850-855. (Pubitemid 351540855)
11. Noseworthy J, Miller D, Compston A: Disease- modifying treatments in multiple sclerosis; in Compston A, et al (eds): McAlpine's Multiple Sclerosis, ed 4. Edinburgh, Churchill Livingstone Elsevier, 2006, pp 729-802.
12. Tanaka M, Tanaka K, Komori M, Saida T: Anti-aquaporin-4 antibody in Japanese multiple sclerosis: the presence of optic-spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin-4 antibody. J Neurol Neurosurg Psychiatry 2007;78:990-992. (Pubitemid 47310840)
13. Saida T, Tashiro K, Itoyama Y, Sato T, Ohashi Y, Zhao Z; Interferon-β1b Multiple Sclerosis Study Group of Japan: Interferon-β1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 2005;64:621-630. (Pubitemid 40261889)
14. Nakashima I, Fukazawa T, Ota K, Nohara C, Warabi Y, Ohashi T, Miyazawa I, Fujihara K, Itoyama Y: Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J Neurol 2007;254:488-492. (Pubitemid 46786725)
15. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J: Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223. (Pubitemid 47355945)